Preclinical Circulating Tumor DNA (ctDNA) Shedding Duration and Prognostic Implications of Modeling 3669 Participants From American Cancer Society Cancer Prevention Study-3 (CPS-3) and Circulating Cell-Free Genome Atlas Substudy 3 (CCGA3)